non-gaap diluted earnings per share for the quarter were $num-one, an increase of num-two% over the prior year quarter while gaap diluted earnings per share for the quarter were $num-three.
we continue to deliver operating leverage with non-gaap operating profit growth of num-one% year-over-year and non-gaap diluted earnings per share of $num-two.
excluding the impact of this gain, our non-gaap earnings per share would have been $num-one.
group revenue for the december quarter was $num-one million, an increase of num-two% over the prior year quarter.
sales in europe, asia and other markets totaled $num-one million, an increase of num-two% over the prior year quarter.
our saas portfolio revenue grew num-one% year-on-year this last quarter, benefiting from the matrixcare acquisition that we lapped during november.
revenue in europe, asia and other markets device sales were $num-one million, an increase of num-two% over the prior year quarter or in constant currency terms, an increase of num-three%.
we were up num-one% in constant currency across our portfolio.
software as a service revenue for the second quarter was $num-one million, an increase of num-two% over the prior year quarter.
looking forward, subject to currency movements and taking into account recent acquisitions, we expect sg&a as a percentage of revenue to be in the range of num-one% to num-two% for the remaining two quarters of fiscal year year-five.
our total assets were $num-one billion and our balance sheet remains strong with modest debt levels.
masks and other sales were $num-one million, an increase of num-two% over the prior year quarter.
looking forward, subject to currency movements, we expect r&d expenses as a percentage of revenue to be in the range of num-one% to num-two% for the balance of fiscal year year-five.
it took around num-one months to see strong sustainable returns from our investments in r&d and our management team at brightree.
taking a closer look at our geographic distribution and excluding revenue from our software as a service business, our sales in u.s., canada and latin america countries were $num-one million, an increase of num-two% over the prior year quarter.
masks and other sales in europe, asia and other markets were $num-one million, an increase of num-two% over the prior year quarter or in constant currency terms, an increase of num-three%.